|
|
|
Volumn 24, Issue 2, 1997, Pages 164-172
|
|
Contributions of protein structure-based drug design to cancer chemotherapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
10 PROPARGYL 5,8 DIDEAZAFOLIC ACID;
ANTINEOPLASTIC AGENT;
BATIMASTAT;
INDINAVIR;
LOMETREXOL;
MATRIX METALLOPROTEINASE;
METESIND GLUCURONATE;
N [[5 [2 (2 AMINO 4,6,7,8 TETRAHYDRO 4 OXO 1H PYRIMIDO[5,4 B][1,4]THIAZIN 6 YL)ETHYL] 2 THIENYL]CARBONYL]GLUTAMIC ACID;
NELFINAVIR;
NOLATREXED;
PELDESINE;
PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE;
PRINOMASTAT;
PROTEINASE;
PURINE NUCLEOSIDE PHOSPHORYLASE;
RITONAVIR;
SAQUINAVIR;
THYMIDYLATE SYNTHASE;
UNCLASSIFIED DRUG;
ZANAMIVIR;
ANTINEOPLASTIC ACTIVITY;
ANTIVIRAL ACTIVITY;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG DESIGN;
DRUG PROTEIN BINDING;
ENZYME INHIBITION;
HAEMOPHILUS INFLUENZAE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
PRIORITY JOURNAL;
PROTEIN CONFORMATION;
PROTEIN TARGETING;
PROTEINASE INHIBITION;
X RAY CRYSTALLOGRAPHY;
ACYLTRANSFERASES;
ANIMALS;
ANTINEOPLASTIC AGENTS;
ANTIVIRAL AGENTS;
DRUG DESIGN;
ENZYME INHIBITORS;
HUMANS;
HYDROXYMETHYL AND FORMYL TRANSFERASES;
METALLOENDOPEPTIDASES;
NEOPLASMS;
PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE;
PURINE-NUCLEOSIDE PHOSPHORYLASE;
THYMIDYLATE SYNTHASE;
|
|
EID: 0030973630
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (20)
|
|
References (46)
|
